NET PROFIT (x1000 DKK)
EMPLOYEES
Hamlet BioPharma AB
Closing information (x1000 DKK)
| Closing information | 2024/06 (consolidated) | 2023/06 (consolidated) | 2022/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
53 |
| Earnings before taxes |
-27,453
|
-12,909
|
-11,979 |
| EBITDA |
-21,619
|
-12,656
|
-11,920 |
| Total assets |
45,014
|
17,993
|
29,069 |
| Current assets |
17,922
|
12,008
|
29,069 |
| Current liabilities |
2,697
|
1,610
|
2,590 |
| Equity capital |
42,317
|
13,225
|
26,479 |
| - share capital |
1,102
|
707
|
770 |
| Employees (average) |
7
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2022/06 |
| Solvency |
94.0%
|
73.5%
|
91.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-61.0%
|
-71.7%
|
-41.0% |
| Current ratio |
664.5%
|
745.8%
|
1122.4% |
| Return on equity (ROE) |
-64.9%
|
-97.6%
|
-45.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
3
|
0
|
0 |
| Chg. No. of employees % | 75% | 0% |
Total value of public sale
| Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.